HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contribution of Interleukin-4 Genotypes to Lung Cancer Risk in Taiwan.

AbstractAIM:
Lung cancer is the leading cause of cancer-related death worldwide. Interleukin-4 (IL-4) is a typical pleiotropic T helper 2 cytokine involved in immunology during carcinogenesis. The present study aimed at evaluating the contribution of IL-4 promoter T-1099G (rs2243248), C-589T (rs2243250), C-33T (rs2070874) genetic polymorphisms to the risk of lung cancer in Taiwan.
MATERIALS AND METHODS:
The contributions of the promoter IL-4 polymorphic genotypes to lung cancer risk were investigated in 358 lung cancer patients and 716 age- and gender-matched healthy controls. In addition, the interaction between IL-4 and individual smoking status was also evaluated.
RESULTS:
The percentages of CC, CT and TT for IL-4 C-589T genotypes were differentially represented as 69.0%, 26.5% and 4.5% in the lung-cancer patient group and 61.3%, 30.4% and 8.3% in the non-cancer control group, respectively (p=0.0156). The TT genotype carriers were of lower risk for lung cancer (odds ratio (OR)=0.48, 95% confidence interval (CI)=0.27-0.86, p=0.0106) than the CC genotype carriers. We also analyzed the allelic frequency distributions and the results showed that the T allele of IL-4 C-589T conducted a protective effect on lung cancer susceptibility (p=0.0022). On the contrary, there was no difference in the distribution of genotypic or allelic frequencies among patients and controls for the IL-4 promoter T-1099G and C-33T.
CONCLUSION:
The TT genotype of IL-4 C-589T compared to the CC wild-type genotype may have a protective effect on lung cancer risk in Taiwan and may serve as an early detection and prediction marker.
AuthorsWen-Shin Chang, Shou-Cheng Wang, Chin-Liang Chuang, Hong-Xue Ji, Chieh-Lun Hsiao, Chin-Mu Hsu, Chia-Wen Tsai, Shih-Ping Liu, Pei-Chen Hsu, Yen-Li Lo, Da-Tian Bau
JournalAnticancer research (Anticancer Res) Vol. 35 Issue 11 Pg. 6297-301 (Nov 2015) ISSN: 1791-7530 [Electronic] Greece
PMID26504066 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Chemical References
  • IL10 protein, human
  • Interleukin-10
Topics
  • Aged
  • Case-Control Studies
  • Female
  • Follow-Up Studies
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Interleukin-10 (genetics)
  • Lung Neoplasms (genetics, pathology)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Polymorphism, Restriction Fragment Length
  • Polymorphism, Single Nucleotide (genetics)
  • Prognosis
  • Promoter Regions, Genetic (genetics)
  • Risk Factors
  • Taiwan

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: